Maryland State Retirement & Pension System Makes New Investment in Azenta, Inc. (NASDAQ:AZTA)

Maryland State Retirement & Pension System acquired a new stake in Azenta, Inc. (NASDAQ:AZTA - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 18,477 shares of the company's stock, valued at approximately $924,000.

Several other large investors also recently modified their holdings of AZTA. Ballentine Partners LLC boosted its stake in shares of Azenta by 2.0% in the fourth quarter. Ballentine Partners LLC now owns 20,340 shares of the company's stock valued at $1,017,000 after buying an additional 404 shares during the period. Picton Mahoney Asset Management boosted its stake in shares of Azenta by 305.7% during the fourth quarter. Picton Mahoney Asset Management now owns 706 shares of the company's stock valued at $35,000 after purchasing an additional 532 shares in the last quarter. Glenmede Trust Co. NA increased its position in Azenta by 6.3% in the 3rd quarter. Glenmede Trust Co. NA now owns 11,379 shares of the company's stock valued at $551,000 after acquiring an additional 679 shares during the period. KBC Group NV increased its stake in shares of Azenta by 48.5% in the fourth quarter. KBC Group NV now owns 2,137 shares of the company's stock valued at $107,000 after buying an additional 698 shares during the period. Finally, Oregon Public Employees Retirement Fund raised its holdings in Azenta by 7.0% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 10,700 shares of the company's stock worth $535,000 after purchasing an additional 702 shares during the last quarter. 99.08% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research firms recently issued reports on AZTA. Evercore ISI boosted their target price on shares of Azenta from $50.00 to $52.00 and gave the company an "in-line" rating in a report on Thursday, February 6th. Stephens reissued an "overweight" rating and issued a $60.00 price target on shares of Azenta in a research note on Thursday, January 2nd. TD Cowen raised shares of Azenta to a "hold" rating in a research report on Thursday, February 27th. Finally, Needham & Company LLC raised their price objective on Azenta from $55.00 to $59.00 and gave the company a "buy" rating in a research note on Thursday, February 6th. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company's stock. According to MarketBeat, Azenta currently has an average rating of "Hold" and an average target price of $58.75.

Remove Ads

Azenta Stock Down 2.4 %

AZTA stock traded down $0.89 during midday trading on Thursday, hitting $35.52. The company's stock had a trading volume of 730,905 shares, compared to its average volume of 586,061. The stock has a market cap of $1.62 billion, a price-to-earnings ratio of -11.92 and a beta of 1.52. Azenta, Inc. has a 1 year low of $35.11 and a 1 year high of $63.58. The stock's 50-day moving average price is $45.82 and its 200 day moving average price is $46.42.

Azenta (NASDAQ:AZTA - Get Free Report) last announced its quarterly earnings results on Wednesday, February 5th. The company reported $0.08 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.05 by $0.03. Azenta had a negative net margin of 24.91% and a positive return on equity of 1.25%. As a group, equities analysts forecast that Azenta, Inc. will post 0.53 earnings per share for the current fiscal year.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.